What is Jade Biosciences, Inc. Common Stock's Market Cap?

Jade Biosciences, Inc. Common Stock's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's Enterprise Value?

Jade Biosciences, Inc. Common Stock's Enterprise Value is $759.9M, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's EV / EBITDA?

Jade Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's Net Income (TTM)?

Jade Biosciences, Inc. Common Stock's Net Income (TTM) is -$153.2M, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's EBITDA?

Jade Biosciences, Inc. Common Stock's EBITDA is -$164.7M, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Jade Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.41, based on as-reported figures from SEC (XBRL) filings.

What is Jade Biosciences, Inc. Common Stock's Net Debt?

Jade Biosciences, Inc. Common Stock's Net Debt is -$461.2M, based on as-reported figures from SEC (XBRL) filings.

Jade Biosciences, Inc. Common Stock (JBIO) Financial Statements

Jade Biosciences, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00WGHZFJ2

XNAS · usd

19.20▼ 0.25 (-1.29%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close19.45

Day's Range19.00 – 20.15

52-Week Range6.91 – 28.00

Volume825.3K

Avg Volume752.8K

Share Statistics

Shares Outstanding

Employees55

ExchangeXNAS

Listed2025-04-29

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Jade Biosciences, Inc. Common Stock (JBIO)

What is Jade Biosciences, Inc. Common Stock's Market Cap?: Jade Biosciences, Inc. Common Stock's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's Enterprise Value?: Jade Biosciences, Inc. Common Stock's Enterprise Value is $759.9M, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's EV / EBITDA?: Jade Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's Net Income (TTM)?: Jade Biosciences, Inc. Common Stock's Net Income (TTM) is -$153.2M, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's EBITDA?: Jade Biosciences, Inc. Common Stock's EBITDA is -$164.7M, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Jade Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.41, based on as-reported figures from SEC (XBRL) filings.
What is Jade Biosciences, Inc. Common Stock's Net Debt?: Jade Biosciences, Inc. Common Stock's Net Debt is -$461.2M, based on as-reported figures from SEC (XBRL) filings.